Open letter: Experts call for urgent expansion of Pretomanid label

Despite trials like TB-PRACTECAL displaying the efficacy of pretomanid in the

expanded BPaLM regimen, the EMA only approved for the BPaL regimen. Experts in

Europe are calling for an update to the label in order to expand access. Read more here.